OTC ECs
This article was originally published in The Tan Sheet
Executive Summary
Safety and regulatory appropriateness of emergency contraceptives available without a prescription stressed by David Grimes, MD, Family Health International, et al., in July issue of Obstetrics & Gynecology. Authors discuss medical and legal implications of issue, arguing "unintended pregnancies remain endemic in the United States, and wider use of emergency contraceptive pills could substantially help." Family Health International has been helping to design label comprehension and actual use studies to support a switch NDA for Women's Capital Corporation's Plan B (1"The Tan Sheet" Dec. 18, 2000, p. 3)
You may also be interested in...
Plan B Emergency Contraceptive Switch NDA Planned
Women's Capital Corporation will file an NDA next year to switch its Plan B emergency contraceptive to OTC status, the company said Dec. 13.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands